Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nipah Virus Shedding in Urine from Fruit Bats, Sri Lanka, 2018-2019.

Emerging infectious diseases·2026
Same author

A mixed methods study on patients' and healthcare professionals' understanding of the graphical presentation of patient-reported outcome data at an inpatient unit for psychosomatic medicine.

Journal of patient-reported outcomes·2026
Same author

First report of pathogenic Leptospira in Sri Lankan bats: A potential reservoir risk?

PLoS neglected tropical diseases·2026
Same author

Resonant breathing in hospitalised psychiatric patients with persistent somatic symptoms: a randomised controlled trial.

General psychiatry·2025
Same author

Country-wide assessment of tick-borne pathogens collected in ticks between 2021 and 2024 in Germany, with a focus on <i>Francisella</i>: A one health pilot study.

One health (Amsterdam, Netherlands)·2025
Same author

Influence of individual illness perception on readiness to change behavior in patients with anorexia nervosa.

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater·2025

Related Experiment Video

Updated: May 17, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Immune changes and neurotransmitters: possible interactions in depression?

Barbara Sperner-Unterweger1, Claudia Kohl, Dietmar Fuchs

  • 1Clinic for Biological Psychiatry, Department of Psychiatry and Psychotherapy, Innsbruck Medical University, Anichstr.35, 6020 Innsbruck, Austria.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|October 23, 2012
PubMed
Summary

Neuroinflammation disrupts neurotransmitter balance, impacting mood and depression in chronic inflammatory diseases. Oxidative stress damages BH4, a key cofactor, reducing catecholamine synthesis and adrenergic pathways.

Keywords:
5,6,7,8-tetrahydrobiopterin5-HTBH(4)DADepressionDopamineGCHGTP cylohydrolase IHIVHUVECIDOIFN-α -ß -γInflammationInterferon-γKyn/TrpLPSNANETNOO(2)(−)ONOO(−)Oxidative stressPAHPKUPhe/TyrPhenylalanineROSSerotoninTDOTNF-αTetrahydrobiopterin (BH4)human immunodeficiency virus infectionhuman umbilical vein endothelial cellsindoleamine 2,3-dioxygenaseinterferon-α, -ß, -γkynurenine to tryptophan ratiol-3,4-dihydroxyphenylalaninel-DOPAlipopolysaccharidenitric oxidenoradrenalinenorepinephrine transporterperoxinitritephenylalanine 4-hydroxylasephenylalanine to tyrosine ratiophenylketonuriareactive oxygen speciessuperoxide aniontryptophan 2,3-dioxygenasetumor necrosis factor-α

More Related Videos

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Related Experiment Videos

Last Updated: May 17, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Neuropsychiatric symptoms like depression are common in chronic inflammatory disorders.
  • The exact pathogenesis of these symptoms, particularly the role of neurotransmitters, remains unclear.
  • Pro-inflammatory stimuli affect both serotonergic and adrenergic systems.

Purpose of the Study:

  • To investigate the role of pro-inflammatory cytokines in neurotransmitter metabolism.
  • To explore the impact of interferon-gamma on catecholamine and serotonin biosynthesis.
  • To elucidate the connection between oxidative stress, BH4 metabolism, and adrenergic dysfunction in inflammatory conditions.

Main Methods:

  • Analysis of neurotransmitter pathways affected by pro-inflammatory cytokines.
  • Investigation of interferon-gamma's effect on 5,6,7,8-tetrahydrobiopterin (BH4) biosynthesis.
  • Assessment of reactive oxygen species' impact on BH4 stability in macrophages.

Main Results:

  • Interferon-gamma stimulates BH4 biosynthesis, a rate-limiting cofactor for serotonin and catecholamines.
  • Interferon-gamma induces reactive oxygen species production, leading to oxidative damage of BH4.
  • Oxidative loss of BH4 in chronic inflammation may reduce catecholamine biosynthesis, affecting adrenergic pathways.

Conclusions:

  • Disturbed catecholamine metabolism is implicated in the pathogenesis of neuropsychiatric symptoms.
  • Oxidative stress-induced BH4 degradation by interferon-gamma may underlie adrenergic dysfunction in chronic inflammatory diseases.
  • Targeting BH4 metabolism and oxidative stress could offer therapeutic strategies for neuropsychiatric symptoms in inflammatory conditions.